Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 52, 2015, Pages 15785-15786

  Nigrovic, Peter A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DRB1 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 6; T LYMPHOCYTE RECEPTOR; HLA ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CHRONIC ARTHRITIS; DISSEMINATED INTRAVASCULAR CLOTTING; FAMILIAL MEDITERRANEAN FEVER; GENETIC ASSOCIATION; GENETIC DISORDER; HAPLOTYPE; HEMOPHAGOCYTIC SYNDROME; HUMAN; MACROPHAGE ACTIVATION SYNDROME; MAJOR HISTOCOMPATIBILITY COMPLEX; NOTE; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; GENETIC PREDISPOSITION; GENETICS; JUVENILE RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTHRITIS, JUVENILE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DRB1 CHAINS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84952684105     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1521837113     Document Type: Note

References (16)

1. ∗11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci USA 112:15970-15975.
2. Raychaudhuri S, et al. (2012) Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44(3):291-296.
3. Scholl PR, et al. (1990) Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. J Immunol 144(1):226-230.
4. Thomson W, et al.; British Paediatric Rheumatology Study Group (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) 41(10):1183-1189.
5. Hollenbach JA, et al. (2010) Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects. Arthritis Rheum 62(6):1781-1791.
6. Singh-Grewal D, Schneider R, Bayer N, Feldman BM (2006) Predictors of disease course and remission in systemic juvenile idiopathic arthritis: Significance of early clinical and laboratory features. Arthritis Rheum 54(5):1595-1601.
7. Nigrovic PA, et al. (2011) Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum 63(2):545-555.
8. Vastert SJ, et al. (2014) Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: Results of a prospective cohort study. Arthritis Rheumatol 66(4):1034-1043.
9. Quartier P, et al. (2011) A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis 70(5):747-754.
10. Mellins ED, Macaubas C, Grom AA (2011) Pathogenesis of systemic juvenile idiopathic arthritis: Some answers, more questions. Nat Rev Rheumatol 7(7):416-426.
11. Nigrovic PA (2014) Review: Is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol 66(6):1405-1413.
12. Horai R, et al. (2004) TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. J Clin Invest 114(11):1603-1611.
13. Akitsu A, et al. (2015) IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2 (+) Vγ6 (+) γδ T cells. Nat Commun 6:7464.
14. Gattorno M, et al. (2008) The pattern of response to antiinterleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 58(5):1505-1515.
15. Shimizu M, Nakagishi Y, Yachie A (2013) Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine 61(2):345-348.
16. McGonagle D, McDermott MF (2006) A proposed classification of the immunological diseases. PLoS Med 3(8):e297.